Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P240005/S010

enVista Envy Hydrophobic Acrylic Intraocular Lens

Bausch + Lomb, Inc. · Decision date Oct 23, 2026

MEDTECHLEDGER EXPLANATIONP240005/S010

What did the FDA decide?

FDA recorded a 30-Day Notice decision, OK30, dated 2026-10-23 for P240005/S010, a supplement to Bausch & Lomb, Inc.'s enVista Envy Hydrophobic Acrylic Intraocular Lens. The listed device category is Lens, multifocal intraocular, with Ophthalmic specialty and product code MFK. The supplement type is 30-Day Notice and the recorded reason is Process Change - Manufacturer/Sterilizer/Packager/Supplier.

The recorded statement covers a lidstock change for the enVista Hydrophobic Acrylic Intraocular Lens and the enVista Envy Hydrophobic Acrylic Intraocular Lens, non-preloaded models. This describes a packaging-material change within the existing PMA rather than a new approval of the lens system. The source record includes no documents, so the specific lidstock materials, any testing performed and the basis for the OK30 decision are not available here.

Whether the change affects sterility assurance or shelf-life claims cannot be determined from the record, and no clinical or labeling conclusions are drawn.

FDA approval order statement

lidstock change for enVista Hydrophobic Acrylic Intraocular Lens & enVista Envy Hydrophobic Acrylic Intraocular Lens non-preloaded models
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Ophthalmic
Decision date
Oct 23, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P240005/S010
Regulatory pathway
PMA supplement
Product code
MFK
Decision code
OK30
Decision date
Oct 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Lens, multifocal intraocular.

Product code
MFK
FDA device class
3

For the original device and its historical approval scope, see PMA P240005. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P240005 · Original PMA

    enVista Envy hydrophobic acrylic intraocular lens (IOL), enVista Envy toric hydrophobic acrylic intraocular lens (IOL)

  2. P240005/S007 · Related supplement

    enVista Envy hydrophobic acrylic intraocular lens (IOL)

  3. P240005/S010 received

    Application receipt date recorded by FDA.

  4. P240005/S008 · Related supplement

    enVista Envy Hydrophobic Acrylic Intraocular Lens

  5. P240005/S009 · Related supplement

    enVista Envy Hydrophobic Acrylic Intraocular Lens

  6. P240005/S010 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P240005. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P240005

Explore the linked device profile

Other records with product code MFK

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Bausch + Lomb, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1400 N. Goodman St., Rochester, NY, 14609

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records